Abstract
Notch signaling plays important roles in the regulation of immune cell functioning during the inflammatory response. Activation of the innate immune signaling receptor NLRP3 promotes inflammation in injured tissue. However, it remains unknown whether Jagged1 (JAG1)-mediated myeloid Notch1 signaling regulates NLRP3 function in acute liver injury. Here, we report that myeloid Notch1 signaling regulates the NLRP3-driven inflammatory response in ischemia/reperfusion (IR)-induced liver injury. In a mouse model of liver IR injury, Notch1-proficient (Notch1FL/FL) mice receiving recombinant JAG1 showed a reduction in IR-induced liver injury and increased Notch intracellular domain (NICD) and heat shock transcription factor 1 (HSF1) expression, whereas myeloid-specific Notch1 knockout (Notch1M-KO) aggravated hepatocellular damage even with concomitant JAG1 treatment. Compared to JAG1-treated Notch1FL/FL controls, Notch1M-KO mice showed diminished HSF1 and Snail activity but augmented NLRP3/caspase-1 activity in ischemic liver. The disruption of HSF1 reduced Snail activation and enhanced NLRP3 activation, while the adoptive transfer of HSF1-expressing macrophages to Notch1M-KO mice augmented Snail activation and mitigated IR-triggered liver inflammation. Moreover, the knockdown of Snail in JAG1-treated Notch1FL/FL livers worsened hepatocellular functioning, reduced TRX1 expression and increased TXNIP/NLRP3 expression. Ablation of myeloid Notch1 or Snail increased ASK1 activation and hepatocellular apoptosis, whereas the activation of Snail increased TRX1 expression and reduced TXNIP, NLRP3/caspase-1, and ROS production. Our findings demonstrated that JAG1-mediated myeloid Notch1 signaling promotes HSF1 and Snail activation, which in turn inhibits NLRP3 function and hepatocellular apoptosis leading to the alleviation of IR-induced liver injury. Hence, the Notch1/HSF1/Snail signaling axis represents a novel regulator of and a potential therapeutic target for liver inflammatory injury.
Similar content being viewed by others
Introduction
Hepatic ischemia/reperfusion injury (IRI) is one of the leading causes of hepatocellular dysfunction or failure during liver transplantation or resection. Hepatic IRI activates liver macrophages (Kupffer cells) and promotes the production of reactive oxygen species (ROS) and proinflammatory cytokines, including TNF-α and IL-1, to trigger a sterile inflammatory response.1 We have demonstrated the importance of NLRP3 function in the mechanism of liver IRI.2 Indeed, as an innate immune signaling receptor, NLRP3 is a key danger signal sensor that drives the inflammatory response in IR-stressed liver.
The Snail family of transcription factors consists of Snail1 (Snail), Snail2 (Slug) and Snail3 (Smuc), which share an evolutionarily conserved role in the processes of cell development and differentiation.3 Snail not only acts primarily as a key regulator of the epithelial−mesenchymal transition but also contributes to cell survival.4,5 Activation of Snail induces anti-inflammatory cytokines and modulates immune responses.6 During tissue inflammation and injury, Snail promotes wound healing through regulation of TGF-β signaling.7 Moreover, Snail regulates cell growth via an ROS-mediated pathway. Disruption of Snail signaling was shown to increase ROS production to cause reduced cell survival under oxidative stress,8 suggesting that Snail may play an important role in the modulation of ROS-mediated inflammation.
Four different Notch receptors (Notch1−4) and five Notch ligands (Jagged1, Jagged2, DLL1, DLL3, and DLL4) have been described in mammals.9 Binding of l proteins to the Notch extracellular domain induce proteolytic cleavage and the release of the Notch intracellular domain (NICD), which binds to the nuclear recombinant recognition sequence binding protein at the Jκ site (RBP-J) to activate Notch target genes.10 Jagged1 (JAG1) is required for the control of cell development.11 Activation of JAG1-mediated Notch1 signaling regulates smooth muscle differentiation and blood vessel formation.12 Increasing the expression of Notch1 and its ligand JAG1 contributes to cell growth and survival during liver regeneration.13 Moreover, Notch signaling controls innate immune cell homeostasis and function.14 Disruption of the transcription factor RBP-J increases cell apoptosis/necrosis and inflammatory responses, resulting in exacerbated liver inflammatory injury.15 Although these studies have shown that Notch signaling is correlated with hepatocellular protection during liver inflammation, it remains largely unknown whether and how JAG1-mediated Notch signaling may regulate the NLRP3-driven inflammatory response in liver IRI.
Here, we identified the novel functional role and regulatory mechanism of JAG1-mediated myeloid Notch1 signaling in liver sterile inflammatory injury. We demonstrate that myeloid Notch1 signaling promotes heat shock transcription factor 1 (HSF1) and Snail activation, which in turn controls NLRP3-mediated innate immunity during IR-triggered liver inflammation.
Results
JAG1-mediated myeloid Notch1 signaling reduces hepatocellular damage in IR-stressed liver
Myeloid-specific Notch1-deficient (Notch1M-KO) and Notch1-proficient (Notch1FL/FL) mice treated with recombinant JAG1 or phosphate buffer saline (PBS) were subjected to liver IR (90 min). After 6 h of reperfusion, JAG1 treatment significantly (p < 0.05) reduced sALT levels in the Notch1FL/FL mice compared to those in the PBS-treated controls (Fig. 1a). In contrast, the disruption of myeloid Notch1 signaling increased sALT levels in Notch1M-KO mice with or without JAG1 treatment. These data correlated with Suzuki’s histological grading of liver IRI (Fig. 1b). Unlike the PBS-treated Notch1FL/FL controls, which showed moderate to severe edema, sinusoidal congestion, and necrosis after liver IRI, the JAG1-treated Notch1FL/FL mice were characterized by reduced edema and sinusoidal congestion and mild necrosis. However, the Notch1M-KO mice showed much more advanced histological damage even after concomitant JAG1 treatment. The JAG1-treated Notch1FL/FL livers showed significantly (p < 0.05) decreased MPO levels, whereas Notch1M-KO increased MPO levels (Fig. 1c) and the mRNA expression of TNF-α, IL-1β, CXCL-10, CXCL-2, MCP1, and CXCL-1 (Fig. 1d).
JAG1-mediated myeloid Notch1 signaling promotes HSF1/Snail activation and inhibits TXNIP/NLRP3 activation and reduces macrophage/neutrophil infiltration in IR-stressed liver
We then asked whether JAG1-mediated myeloid Notch1 signaling may influence HSF1 and Snail activation in IR-stressed liver. JAG1 treatment in the /FL livers increased NICD, HSF1, Snail, and thioredoxin (TRX)1 expression but reduced thioredoxin-interacting protein (TXNIP), NLRP3, ASC, and cleaved caspase-1 protein expression compared to that in PBS-treated controls (Fig. 2a). However, Notch1M-KO with or without JAG1 treatment diminished NICD, HSF1, Snail, and TRX1 activation and enhanced TXNIP, NLRP3, ASC, and cleaved caspase-1 activation (Fig. 2a), leading to significantly (p < 0.01) increased IL-1β release (Fig. 2b). The JAG1-treated Notch1FL/FL livers showed reduced CD11b+ macrophage (Fig. 2c) and Ly6G+ neutrophil trafficking (Fig. 2d) compared to that in PBS-treated controls, whereas Notch1M-KO increased CD11b+ macrophage (Fig. 2c) and Ly6G+ neutrophil accumulation (Fig. 2d) even in the presence of JAG1 treatment.
JAG1-mediated myeloid Notch1 signaling reduces hepatocellular apoptosis/necrosis in IR-stressed liver
To determine whether the activation of JAG1-mediated myeloid Notch1 signaling may regulate cell apoptosis in response to liver IRI, we performed TUNEL staining to analyze IR-induced hepatocellular apoptosis in ischemic livers. Indeed, livers in JAG1-treated Notch1FL/FL mice showed a reduced number of apoptotic TUNEL+ cells compared to that in PBS-treated controls (Fig. 3a). However, the number of TUNEL+ cells was significantly (p < 0.01) increased in the Notch1M-KO mice even with concomitant JAG1 treatment (Fig. 3a). An ELISA assay revealed that JAG1 treatment significantly (p < 0.01) reduced serum TNF-α production in the Notch1FL/FL mice, whereas Notch1M-KO mice showed increased TNF-α production (Fig. 3b). Western blot analysis revealed that JAG1 treatment in the Notch1FL/FL livers upregulated Bcl-2 and Bcl-xL expression but downregulated p-ASK1 and cleaved caspase-3 expression compared to that in PBS-treated controls (Fig. 3c). In contrast, Notch1M-KO livers showed reduced Bcl-2 and Bcl-xL expression but augmented p-ASK1 and cleaved caspase-3 expression (Fig. 3c). Moreover, increased HMGB1 production was observed in the Notch1M-KO mice but not in the JAG1-treated Notch1FL/FL mice (Fig. 3d).
Myeloid Notch1 signaling-induced HSF1 expression activates Snail and regulates NLRP3-mediated immune responses in IR-stressed liver
Next, we evaluated the functional role of myeloid Notch1 signaling-induced HSF1 expression in IR-stressed liver. BMMs were transfected with lentivirus expressing HSF1 (Lv-HSF1) or a GFP control (Lv-GFP) and adoptively transferred into Notch1M-KO mice. Unlike livers treated with Lv-GFP-transfected BMMs or control cells, livers in Notch1M-KO mice treated with Lv-HSF1-transfected cells showed a reduction in IR-induced hepatocellular damage, as evidenced by the decrease in the Suzuki histological score (Fig. 4a) and sALT levels (Fig. 4b). Moreover, the adoptive transfer of Lv-HSF1-transfected cells into the Notch1M-KO ischemic livers decreased the cellular expression of 4-hydroxynonenal (4-HNE), a marker of ROS production16 (Fig. 4c). Liver treated with Lv-HSF1-transfected cells showed increased Snail and TRX1 expression but reduced TXNIP, NLRP3, and ASC expression (Fig. 4d), which was accompanied by diminished IL-1β release (Fig. 4e) compared to that in the Lv-GFP-treated group or cell controls.
Myeloid Notch1 signaling controls NLRP3 function in a Snail-dependent manner in IR-stressed liver
As myeloid Notch1-induced HSF1 signaling promoted Snail activation in IR-stressed liver, we then asked whether Snail is required for the regulation of NLRP3 activation in response to liver IRI. We disrupted Snail in Notch1FL/FL livers with an in vivo mannose-mediated Snail siRNA delivery system specifically targeted to macrophages.2 Unlike the administration of nonspecific (NS) siRNA in the JAG1-treated Notch1FL/FL mice, the knockdown of Snail significantly (p < 0.05) increased the sALT levels (Fig. 5a) and IR-induced liver damage (Fig. 5b) in the JAG1-treated Notch1FL/FL mice. Snail siRNA treatment in the JAG1-treated Notch1FL/FL livers increased CD11b+ macrophage (Fig. 5c) and neutrophil (Fig. 5d) accumulation. Moreover, Snail knockdown reduced TRX1 expression but augmented TXNIP, NLRP3, ASC, and cleaved caspase-1 expression (Fig. 5e), leading to increased IL-1β production (Fig. 5f) and TNF-α, IL-1β, CXCL-10, CXCL-2, and MCP1 expression (Fig. 5g).
Notch1 signaling-induced HSF1 expression promotes Snail activation and inhibits NLRP3 activation in macrophages
Having demonstrated the importance of JAG1-mediated myeloid Notch1 signaling in the regulation of HSF1/Snail and NLRP3 function in vivo, we next tested whether there was crosstalk between Notch1 signaling-induced HSF1 and Snail that affected the control of NLRP3-mediated immune responses selectively in macrophages. We found increased NICD and HSF1 protein expression in Notch1FL/FL macrophages after JAG1 treatment (Fig. 6a). Notably, JAG1-treated Notch1FL/FL macrophages showed increased Snail protein expression, while Notch1M-KO inhibited HSF1 and Snail expression (Fig. 6a). Immunofluorescence staining revealed increased Snail expression in Notch1FL/FL but not in Notch1M-KO macrophages after JAG1 treatment (Fig. 6b). Moreover, the transfection of Notch1FL/FL macrophages with p-CRISPR-HSF1 KO reduced Snail expression but augmented NLRP3 and ASC expression compared to that in the control vector-treated cells (Fig. 6c). This was further confirmed by the immunofluorescence staining data, which showed that p-CRISPR-HSF1 KO reduced Snail expression in JAG1-treated macrophages (Fig. 6d), which was accompanied by the increased mRNA expression of TNF-α, IL-1β, CXCL-10, CXCL-2, and MCP1 (Fig. 6e).
Snail is crucial for the Notch1 signaling-mediated immune regulation of NLRP3 activation in macrophages
To elucidate the mechanistic role of Snail in the regulation of NLRP3 function in Notch1 signaling-mediated immune regulation, BMMs from Notch1FL/FL and Notch1M-KO mice were transfected with the p-CRISPR-Snail KO, p-CRISPR-Snail or control vector followed by JAG1 and LPS treatment. Clearly, unlike control vector treatment, transfection of JAG1-treated Notch1FL/FL cells with p-CRISPR Snail KO diminished TRX1 expression but markedly increased TXNIP, NLRP3, ASC, and cleaved caspase-1 expression (Fig. 7a) accompanied by augmented ROS production (Fig. 7b), caspase-1 activity (Fig. 7c), and IL-1β release (Fig. 7d). In contrast, the induction of Snail by transfecting Notch1M-KO cells with p-CRISPR-Snail resulted in increased TRX1 expression and reduced TXNIP, NLRP3, ASC, and cleaved caspase-1 expression (Fig. 7e), ROS production (Fig. 7f), caspase-1 activity (Fig. 7g), and IL-1β release (Fig. 7h) compared to that in control vector-treated cells after LPS stimulation.
Snail is essential for the regulation of hepatocellular apoptosis/necrosis during Notch1 signaling-mediated immune regulation
To dissect the molecular mechanism of JAG1-mediated Notch1 signaling involved in the modulation of hepatocyte apoptosis/necrosis during liver IRI, we used a BMM/hepatocyte coculture system (Fig. 8a). BMMs from Notch1FL/FL mice were transfected with p-CRISPR-Snail KO or a control vector followed by JAG1 and LPS treatment and then cocultured with hepatocytes supplemented with H2O2. We found that BMMs transfected with p-CRISPR Snail KO showed markedly increased TNF-α (Fig. 8b) and HMGB1 (Fig. 8c) release compared to that of the control vector-treated groups in the coculture supernatants. Interestingly, increased LDH release from stressed hepatocytes was observed after coculture with CRISPR Snail KO-BMMs but not with control-treated cells (Fig. 8d). The expression of p-ASK1 and cleaved caspase-3 in stressed hepatocytes was significantly (p < 0.05) increased after coculture with CRISPR Snail KO-BMMs (Fig. 8e). Moreover, immunofluorescence staining revealed an increased number of apoptotic TUNEL+ hepatocytes after coculture with CRISPR Snail KO-BMMs compared with that in the control-treated groups (Fig. 8f).
Discussion
To the best of our knowledge, this study is the first to document that JAG1-mediated myeloid Notch1/HSF1/Snail signaling is crucial for modulating NLRP3-mediated immune responses in response to IR-triggered liver inflammation. The principal findings are as follows: (i) JAG1-mediated myeloid Notch1 signaling alleviates IR-induced liver damage and reduces macrophage/neutrophil trafficking and proinflammatory mediator expression; (ii) JAG1-mediated myeloid Notch1 signaling promotes HSF1/Snail activation and inhibits NLRP3/caspase-1 activity; (iii) JAG1-mediated myeloid Notch1 signaling promotes antiapoptotic functioning and inhibits proapoptotic activity during IR-induced hepatocyte apoptosis; (iv) JAG1-mediated myeloid Notch1 signaling controls NLRP3 function and hepatocellular apoptosis via a Snail-dependent pathway. Our results highlight the importance of JAG1-mediated myeloid Notch1/HSF1/Snail signaling as a key regulator of NLRP3 activation and cell apoptosis during IR stress-mediated liver inflammation (Fig. 9).
The Notch pathway is one of the most frequently activated signaling pathways in human liver diseases. Since Notch signaling regulates multiple cell activities, the deregulation of the Notch cascade has been found to contribute to many pathological processes.10 The activation of Notch signaling by TLR4 stimulation can regulate gene expression patterns involved in proinflammatory responses.17 However, JAG1-mediated Notch1 signaling induces regulatory T-cell (Treg) production and exerts an immunoregulatory effect, whereas blockade of JAG1/Notch1 signaling inhibits Treg suppressor function both in vitro and in vivo.18 Induction of the Notch intracellular domain (NICD) suppresses proinflammatory cytokine expression while enhancing anti-inflammatory mediator expression in TLR-stimulated macrophages.19 Moreover, Notch1 and its target gene Hes1 can inhibit the inflammatory response via an inhibitory feedback loop and transcriptional regulation.20,21 Disruption of myeloid Notch1 activity activates RhoA/ROCK signaling and exacerbates liver inflammation.22 These results suggest that Notch signaling modulates the inflammatory response through multiple mechanisms. The present study characterized a molecular circuit responsible for the regulatory effect of JAG1-mediated myeloid Notch1 signaling on NLRP3 function during liver IRI. We found that JAG1-mediated myeloid Notch1 signaling activated HSF1 and Snail, which in turn inhibited NLRP3 activation leading to reduced IR-induced liver inflammation. Our findings reveal a novel mechanism in which JAG1-mediated myeloid Notch1 signaling regulates the NLRP3-mediated innate immune response in IR-stressed livers.
HSF1 is the master transcriptional regulator of cellular responses to heat and a wide variety of other stressors. Increased levels of HSF1 facilitate survival in response to stress by coordinating a variety of fundamental cellular processes.23 Biochemical and genetic studies have clearly demonstrated critical roles for HSF1 in resistance to stress-induced inflammation and programmed cell death.24 Activation of HSF1 inhibits IL-1β-mediated inflammation, whereas the disruption of HSF1 augments proinflammatory TNF-α and IL-6 production in response to endotoxin stress.25 However, it is unknown how JAG1-mediated myeloid Notch signaling may interact with HSF1 in IR-stressed livers. We found that Notch1FL/FL mice treated with JAG1 showed increased NICD and HSF1 levels, whereas Notch1M-KO mice showed inhibited HSF1 expression, suggesting that JAG1-mediated Notch1 signaling mediates HSF1 activation. These data were consistent with a previous report that showed that Notch1 binds to the promoters of HSF1 to regulate the heat shock response pathway.26 Moreover, further evidence revealed that the adoptive transfer of BMMs pretreated with lentivirus expressing HSF1 into Notch1M-KO mice ameliorated IR-induced hepatocellular damage. Thus, HSF1 is crucial for Notch1 signaling-mediated immune regulation in response to IR stress.
It is interesting to note that HSF1 induction inhibited ROS production, as evidenced by the reduced expression of 4-HNE, a key oxidative stress marker, in ischemic livers. Indeed, HNE activates stress response pathways, including antioxidant, endoplasmic reticulum stress, DNA damage, and heat shock response pathways.27 Notably, JAG1-mediated Notch1 signaling or HSF1 induction activated Snail, a critical gene for the control of cell movement and survival,5 whereas CRISPR/Cas9-mediated HSF1 knockout inhibited Snail while increasing NLRP3 and inflammatory cytokine expression. Moreover, although immunofluorescence staining revealed that JAG1 treatment increased Snail expression in macrophages, the disruption of HSF1 reduced Snail expression even during JAG1 treatment. These results suggest that HSF1 is essential for the activation of Snail, which may play an important regulatory role in Notch1 signaling-mediated immune regulation during liver IRI.
It is not known which other mechanisms may confer Snail with the ability to selectively affect NLRP3 activation during Notch1 signaling-mediated immune regulation. We found that the disruption of Snail with siRNA treatment aggravated IR-induced hepatocellular damage by increasing the expression of TXNIP, a critical signaling molecule involved in mediating NLRP3 activation.28 Indeed, TXNIP is an endogenous inhibitor and regulator of TRX. Enhanced TXNIP expression inhibits TRX activity and thus can modulate the cellular redox state and increase oxidative stress.29 Under the influence of ROS, TXNIP is translocated from the nucleus and binds to TRX1 in the cytosol, leading to increased ROS generation.30 Increased amounts of ROS can oxidize TRX1. The oxidized form of TRX1 is not able to bind to TXNIP, which is separated from TRX1. Free TXNIP physically interacts with the LRR domain of NLRP3 and activates NLRP3.28 Consistent with these results, TRX1 expression was markedly reduced in Snail siRNA-treated Notch1FL/FL livers but not in NS siRNA-treated control livers after IR. Further evidence was produced by an in vitro study, which showed that the induction of Snail significantly increased TRX1 production but reduced TXNIP and ROS production, whereas the disruption of Snail increased ROS production and enhanced TXNIP/NLRP3 activation, resulting in increased caspase-1 activity and IL-1β release in LPS-stimulated macrophages. Thus, Snail regulates NLRP3 function through inhibiting ROS production and regulating the TXNIP/TRX1 complex in response to IR stress. Our findings demonstrate the unexpected role of myeloid Notch1 signaling-induced Snail activation in negatively modulating the NLRP3-mediated innate immune response during IR-triggered liver inflammation.
One striking finding was that myeloid Notch1-induced Snail activation could be involved in the modulation of apoptotic pathways during liver IRI. Indeed, both programmed cell death (apoptosis) and necrosis appear to be ongoing processes during liver IRI. Previous studies showed that TXNIP directly binds to TRX to inhibit its expression and activity.31 TRX has been identified as a binding partner of ASK1, a key regulator of oxidative stress-induced apoptosis in many types of cells through the activation of the JNK and p38 MAPK pathways.32 Under oxidative stress conditions, ROS induce the oxidation of TRX, leading to the dissociation of ASK1 from TRX and the activation of ASK1.33 In addition, TXNIP also binds and inhibits TRX, thus increasing the availability of activated ASK1.34 Thus, ASK1 could be critical to the Notch1/Snail-mediated regulation of the apoptotic process. As a result of the latter observation, we examined apoptotic liver cell death by TUNEL staining in vivo. JAG1 treatment of Notch1FL/FL livers activated NICD and Snail, which was accompanied by a reduced number of apoptotic TUNEL+ cells after IR. However, disruption of Notch1 inhibited Snail activation, leading to markedly increased IR-induced cell apoptosis in Notch1M-KO livers even during JAG1 treatment. Notably, enhanced ASK1 activation was found in Notch1M-KO but not in Notch1FL/FL livers. Moreover, using an in vitro macrophage/hepatocyte coculture system, we observed that the disruption of Snail in macrophages activated ASK1 in hepatocytes after coculture. Further evidence was produced by the immunofluorescence staining of hepatocytes after coculture with macrophages, which showed that the deletion of Snail in macrophages significantly increased the number of apoptotic TUNEL+ hepatocytes during H2O2-induced oxidative stress. Consistent with the in vivo study, JAG1 treatment increased antiapoptotic Bcl-2/Bcl-xL expression, whereas Snail deficiency in macrophages enhanced caspase-3 activation. Our findings demonstrate that Snail is a key regulator of ASK1-mediated hepatocyte apoptosis/necrosis in IR-stressed livers.
Another important implication of our results is that myeloid Notch1-induced Snail activation could also influence HMGB1 release during liver IRI. Indeed, HMGB1 can be released from macrophages and hepatocytes in response to oxidative stress. As an early mediator of inflammation, HMGB1 provides danger signals that activate immune cells and promote inflammatory responses and tissue damage during liver IRI. Inhibition of HMGB1 activity significantly diminished IR-induced hepatocellular damage.35 Although reduced serum levels of HMGB1 were observed in JAG1-treated Notch1FL/FL mice, the disruption of myeloid Notch1 signaling augmented HMGB1 release in Notch1M-KO mice. Because Snail is required for cell survival under oxidative stress conditions,8 it also appears to be involved in the modulation of HMGB1-mediated inflammation in liver IRI. Consistent with our in vitro data demonstrating the ability of Snail to inhibit HMGB1 induction in the coculture system, the disruption of Snail in macrophages increased HMGB1 release and hepatocyte death in H2O2-stressed hepatocytes. This result suggests that Snail may be crucial for the modulation of HMGB1-mediated inflammation and the reduction of hepatocellular damage in IR-triggered sterile liver inflammation. Taken together, our findings reveal the essential role of myeloid Notch-induced Snail activation in the regulation of apoptotic/necrotic pathways during liver IRI.
Figure 9 depicts the putative molecular mechanisms by which JAG1-mediated myeloid Notch1 signaling may regulate NLRP3 inflammasome-driven inflammatory responses in liver IRI. IR stress activates Notch1 signaling and induces ROS production in ischemic livers. Upon ligand binding, Notch1 is cleaved by γ-secretase, releasing the intracellular domain (NICD), which translocates into the nucleus and forms a complex with the CSL DNA-binding protein to activate HSF1; HSF1, in turn, promotes Snail activation and regulates the TRX1/TXNIP and TRX1/ASK1 complexes, leading to reduced NLRP3 inflammasome activation and ROS-induced hepatocellular apoptosis/necrosis during IR-triggered liver inflammation.
In conclusion, we demonstrated that JAG1-mediated myeloid Notch1 signaling promotes HSF1 and Snail activation, which in turn inhibit TXNIP/NLRP3 functioning and the apoptotic/necrotic pathway in IR-stressed livers. By identifying the molecular pathways by which JAG1-mediated myeloid Notch1/HSF1/Snail signaling regulates NLRP3-mediated innate immunity, our novel findings provide a rationale for the refinement of therapeutic approaches to ameliorate sterile inflammatory liver injury.
Materials and methods
Animals
Floxed Notch1 (Notch1FL/FL) mice (The Jackson Laboratory, Bar Harbor, ME) and mice expressing the Cre recombinase under the control of the lysozyme 2 (Lyz2) promoter (LysM-Cre; The Jackson Laboratory) were used to generate myeloid-specific Notch1 knockout (Notch1M-KO) mice, as described.22 Mouse genotyping was performed using a standard protocol with primers described in the JAX Genotyping protocols database. Animals at 6–8 weeks of age were used in all experiments. This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. The study protocols were approved by the Institutional Animal Care and Use Committee of The University of California, Los Angeles and Shanghai Jiaotong University in China.
Mouse liver IRI model
We used an established mouse model that utilized warm hepatic ischemia followed by reperfusion.2 Mice were injected with heparin (100 U/kg), and an atraumatic clip was used to interrupt the arterial/portal venous blood supply to the cephalad liver lobes. After 90 min of ischemia, the clip was removed, and mice were sacrificed after 6 h of reperfusion. Some animals were injected via the tail vein with bone marrow-derived macrophages (BMMs, 5 × 106 cells in PBS/mouse) transfected with lentivirus-expressing HSF1 (Lv-HSF1) 24 h prior to ischemia, and some animals were injected i.v. with Snail siRNA or nonspecific (control) siRNA (2 mg/kg) (Santa Cruz Biotechnology, CA) mixed with mannose-conjugated polymers (Polyplus transfection™, Illkirch, France) at a ratio defined according to the manufacturer’s instructions 4 h prior to ischemia, as described.2 Some animals were injected i.v. with recombinant JAG1 (0.5 mg/kg, R&D Systems) or PBS 1 h prior to ischemia.
Hepatocellular function assay
The levels of serum alanine aminotransferase (sALT), an indicator of hepatocellular injury, were measured by IDEXX Laboratories (Westbrook, ME).
Histology, immunohistochemistry, and immunofluorescence staining
Liver sections (5 μm) were stained with hematoxylin and eosin (H&E). The severity of IRI was graded using Suzuki’s criteria36 on a scale from 0 to 4. Liver macrophages were detected using rat anti-mouse CD11b Ab (BD Biosciences) as the primary antibody and Alexa Fluor 594 anti-rat IgG as the secondary antibody for immunofluorescence staining. DAPI was used for nuclear counterstaining. Liver neutrophils were detected using primary rat anti-mouse Ly6G Ab (BD Biosciences). Biotinylated goat anti-rat IgG (Vector, Burlingame, CA) was used as a secondary antibody for immunohistochemistry staining. Snail in macrophages was detected using rabbit anti-mouse Snail Ab (Cell Signaling Technology, MA) as a primary antibody and Alexa Fluor-conjugated AffiniPure donkey anti-rabbit IgG Ab (Jackson Immunoresearch, PA) as a secondary antibody, and macrophages were incubated with immunoperoxidase (ABC Kit, Vector) according to the manufacturer’s instructions. The positive cells were counted blindly at 10 HPF/section (200×).
Myeloperoxidase activity assay
The presence of myeloperoxidase (MPO) was used as an index of hepatic neutrophil accumulation.2 The change in absorbance was measured spectrophotometrically at 655 nm. One unit of MPO activity was defined as the quantity of enzyme that degraded 1 μmol peroxide/min at 25 °C per gram of tissue.
TUNEL assay
The Klenow-FragEL DNA Fragmentation Detection Kit (EMD Chemicals, Gibbstown, NJ) was used to detect DNA fragmentation characteristic of oncosis/ apoptosis/necrosis in formalin-fixed paraffin-embedded liver sections.22 The apoptosis of primary hepatocytes was measured by using a Cell Meter TUNEL Apoptosis Assay Kit (AAT Bioquest, Sunnyvale, CA). Briefly, treated hepatocytes were fixed in 4% paraformaldehyde for 30 min. After three washes with TBST, the hepatocytes were incubated with TunnelyteTM Green for 60 min at 37 °C. Additional Hoechst staining was conducted for nucleus identification. The TUNEL-positive cells were visually identified by fluorescence microscopy by using an FITC filter. The results were scored semiquantitatively by averaging the number of apoptotic cells/microscopic field at ×200 magnification. Ten fields were evaluated per sample.
Quantitative RT-PCR analysis
Quantitative real-time PCR was performed as previously described.2 Total RNA was purified from liver tissue or cell cultures using the RNeasy Mini Kit (Qiagen, Chatsworth, CA) according to the manufacturer’s instructions. Reverse transcription to generate cDNA was performed by using the SuperScript III First Strand Synthesis System (Invitrogen). Quantitative real-time PCR was performed using the DNA Engine with Chromo 4 Detector (MJ Research, Waltham, MA). To a final reaction volume of 25 μl, the following were added: 1× SuperMix (Platinum SYBR Green qPCR Kit; Invitrogen, San Diego, CA), cDNA and 10 μM of each primer. The amplification conditions were as follows: 50 °C (2 min) and 95 °C (5 min) followed by 40 cycles of 95 °C (15 s) and 60 °C (30 s). The primer sequences used for the amplification of TNF-α, IL-1β, MCP-1, CXCL-1, CXCL-2, CXCL-10, and HPRT are shown in Supplementary Table 1. Target gene expression was calculated according to the ratio of target gene expression to that of the housekeeping gene HPRT.
Western blot analysis
Protein was extracted from liver tissue or cell cultures as described.2 Protein was extracted from liver tissue or cell cultures with ice-cold protein lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% sodium dodecyl sulfate, 1% sodium deoxycholate, and 1% Triton-100). Proteins (30 µg/sample) in SDS-loading buffer (50 mM Tris, pH 7.6, 10% glycerol, and 1% SDS) were subjected to 4–20% SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA). The membrane was blocked with 5% dry milk and 0.1% Tween 20 (USB, Cleveland, OH). Monoclonal rabbit anti-mouse NICD, HSF1, Snail, TRX1, TXNIP, NLRP3, ASC, cleaved caspase-1, p-ASK1, ASK1, Bcl-2, Bcl-xL, cleaved caspase-3, and β-actin Abs (Cell Signaling Technology, MA) were used. The membranes were incubated with the Abs and then developed according to the Pierce SuperSignal West Pico Chemiluminescent Substrate protocol (Pierce Biotechnology, Rockford, IL). The relative quantities of protein were determined using a densitometer (Kodak Digital Science 1D Analysis Software, Rochester, NY) and expressed in absorbance units (AU) by comparison with β-actin expression.
Lentiviral vector construction
The HSF1 lentiviral vector (p-Lv-HSF1, Applied Biological Materials Inc., Canada), which expresses HSF1 and contains a CMV promoter and a kanamycin gene, was packaged with psPAX2 and pVSVG (Addgene). The 293T cell line was cultured in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Cells were seeded in six-well plates and transfected when they reached 60–70% confluence. Cells were cotransfected with p-Lv-HSF1, psPAX2 and pVSVG using Lipofectamine 3000 reagent (Invitrogen) to package the lentiviruses according to the manufacturer’s instructions. The following amounts of plasmid DNA were used per well: 1 μg of p-Lv-HSF1 (or control vector), 0.625 μg of psPAX2, and 0.375 μg of pCMV-VSVG. Forty-eight hours after transfection, the viral vector-containing supernatant was collected and filtered through a 0.45 μm filter. The HSF1 lentivirus (Lv-HSF1) was either used immediately or snap-frozen at −80 °C for later use. The GFP lentivirus (Lv-GFP, Applied Biological Materials Inc.) was used as a control.
Primary hepatocyte/BMM isolation and in vitro transfection
Murine primary hepatocytes and bone-derived macrophages (BMMs) were isolated from Notch1FL/FL and Notch1M-KO mice as described.2 In brief, livers were perfused in situ with warmed (37˚C) HBSS solution followed by collagenase buffer (collagenase type IV, Sigma, St Louis, MO). The perfused livers were dissected and strained through 70-μm nylon mesh cell strainers (BD Biosciences). The nonparenchymal cells (NPCs) were separated from the hepatocytes by centrifugation three times at 50 × g for 2 min. The NPCs were suspended in HBSS and layered onto a 50%/25% two-step Percoll gradient (Sigma) in a 50-ml conical centrifuge tube and centrifuged at 1800 × g at 4 °C for 15 min. Bone marrow cells were removed from the femurs and tibias of the Notch1FL/FL and Notch1M-KO mice and cultured in DMEM supplemented with 10% FBS and 15% L929-conditioned medium. BMMs (1 × 106/well) were cultured for 7 days and then transfected with CRISPR/Cas9-mediated HSF1 KO (p-CRISPR-HSF1 KO), CRISPR/Cas9-mediated Snail KO (p-CRISPR-Snail KO), CRISPR/Cas9-mediated Snail activation (p-CRISPR-Snail) or control vector. After 48 h, the cells were treated with 2 µg/ml JAG1 supplemented with 100 ng/ml LPS for an additional 6 h.
Coculture of macrophages and primary hepatocytes
Primary hepatocytes were cultured in six-well plates at a concentration of 4 × 105 cells per well. After 24 h, 0.4 μm-pore size Transwell inserts (Corning) containing 1 × 106 BMMs were placed into the six-well plates with the hepatocytes that were initially seeded. The cocultures were incubated for 12 h with or without the addition of H2O2 (200 µM) to the lower chamber.
ELISA assay
Murine serum and cell culture supernatants were harvested for cytokine analysis. ELISA kits were used to measure the TNF-α, IL-1β, and HMGB1 levels (eBiosciences).
LDH activity assay
BMMs (1 × 106) were cultured with primary hepatocytes (4 × 105/well) for 12 h with or without the addition of H2O2 (200 µM) to the lower chamber. The activity of lactate dehydrogenase (LDH) in the cell culture medium from the lower chamber was measured with a commercial LDH activity assay kit (Stanbio Laboratory, Boerne, TX) according to the manufacturer’s instructions.
Reactive oxygen species assay
ROS production in BMMs was measured using 5- and 6-carboxy-2′,7′-difluorodihydrofluorescein diacetate (Carboxy-H2DFFDA, Life Technologies) as described.2 In brief, BMMs from Notch1FL/FL and Notch1M-KO mice were transfected with CRISPR/Cas9-Snail KO, CRISPR/Cas9-Snail activation or control vector and then cultured on collagen-coated coverslips after LPS stimulation. After washing with PBS, the cells were incubated with 10 μM of Carboxy-H2DFFDA. Carboxy-H2DFFDA was converted to a fluorescent green form when it was hydrolyzed by intracellular esterases and oxidized in cells. The cells were then fixed with 2% paraformaldehyde and stained with Hoechst dye. The ROS produced by the BMMs was analyzed and quantified by fluorescence microscopy. Positive green fluorescent-labeled cells were counted blindly at 10 HPF/section (200×).
Caspase-1 enzymatic activity assay
Caspase-1 enzymatic activity was determined by a colorimetric assay kit (R&D System), as described.37 Briefly, after coculture with MSCs, 50 µl of cell lysate from BMMs was added to 50 µl of caspase-1 reaction buffer in a 96-well flat bottom microplate. Each sample was then added to 200 mM caspase-1 substrate and WEHD-pNA, followed by 2 h of incubation at 37 °C. The enzymatic activity of caspase-1 was measured with an ELISA reader at a wavelength of 405 nm.
Statistical analysis
Data are expressed as the mean ± SD and were analyzed by the permutation t test and Pearson correlation. Two-sided p values less than 0.05 were considered statistically significant. Multiple group comparisons were made using one-way ANOVA followed by Bonferroni’s post hoc test. When the groups showed unequal variances, we applied Welch’s ANOVA to generate the multiple group comparisons. All analyses were performed by using SAS/STAT software, version 9.4.
References
Lentsch, A. B., Kato, A., Yoshidome, H., McMasters, K. M. & Edwards, M. J. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32, 169–173 (2000).
Yue, S. et al. The myeloid heat shock transcription factor 1/beta-catenin axis regulates NLR family, pyrin domain-containing 3 inflammasome activation in mouse liver ischemia/reperfusion injury. Hepatology 64, 1683–1698 (2016).
Nieto, M. A. The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol. 3, 155–166 (2002).
Carver, E. A., Jiang, R., Lan, Y., Oram, K. F. & Gridley, T. The mouse snail gene encodes a key regulator of the epithelial−mesenchymal transition. Mol. Cell Biol. 21, 8184–8188 (2001).
Barrallo-Gimeno, A. & Nieto, M. A. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132, 3151–3161 (2005).
Kudo-Saito, C., Shirako, H., Takeuchi, T. & Kawakami, Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15, 195–206 (2009).
Hotz, B., Visekruna, A., Buhr, H. J. & Hotz, H. G. Beyond epithelial to mesenchymal transition: a novel role for the transcription factor Snail in inflammation and wound healing. J. Gastrointest. Surg. 14, 388–397 (2010).
Kim, N. H. et al. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress. Nat. Commun. 8, 14374 (2017).
Mumm, J. S. & Kopan, R. Notch signaling: from the outside in. Dev. Biol. 228, 151–165 (2000).
Kopan, R. & Ilagan, M. X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216–233 (2009).
Shimizu, K., Chiba, S., Saito, T., Kumano, K. & Hirai, H. Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. Biochem. Biophys. Res. Commun. 276, 385–389 (2000).
Manderfield, L. J. et al. Notch activation of Jagged1 contributes to the assembly of the arterial wall. Circulation 125, 314–323 (2012).
Kohler, C. et al. Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration. Hepatology 39, 1056–1065 (2004).
Radtke, F., MacDonald, H. R. & Tacchini-Cottier, F. Regulation of innate and adaptive immunity by Notch. Nat. Rev. Immunol. 13, 427–437 (2013).
Yu, H. C. et al. Canonical notch pathway protects hepatocytes from ischemia/reperfusion injury in mice by repressing reactive oxygen species production through JAK2/STAT3 signaling. Hepatology 54, 979–988 (2011).
Liou, G. Y. & Storz, P. Detecting reactive oxygen species by immunohistochemistry. Methods Mol. Biol. 1292, 97–104 (2015).
Palaga, T. et al. Notch signaling is activated by TLR stimulation and regulates macrophage functions. Eur. J. Immunol. 38, 174–183 (2008).
Ostroukhova, M. et al. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J. Clin. Invest. 116, 996–1004 (2006).
Zhang, Q. et al. Notch signal suppresses Toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor kappaB activation. J. Biol. Chem. 287, 6208–6217 (2012).
Hu, X. et al. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. Immunity 29, 691–703 (2008).
Shang, Y. et al. The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation. Nat. Immunol. 17, 930–937 (2016).
Lu, L. et al. Myeloid Notch1 deficiency activates the RhoA/ROCK pathway and aggravates hepatocellular damage in mouse ischemic livers. Hepatology 67, 1041–1055 (2018).
Dai, C., Whitesell, L., Rogers, A. B. & Lindquist, S. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130, 1005–1018 (2007).
Tanaka, K. et al. Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis. J. Biol. Chem. 282, 23240–23252 (2007).
Xie, Y., Chen, C., Stevenson, M. A., Auron, P. E. & Calderwood, S. K. Heat shock factor 1 represses transcription of the IL-1beta gene through physical interaction with the nuclear factor of interleukin 6. J. Biol. Chem. 277, 11802–11810 (2002).
Kourtis, N. et al. Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia. Nat. Med. 24, 1157–1166 (2018).
West, J. D. & Marnett, L. J. Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 18, 1642–1653 (2005).
Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136–140 (2010).
Spindel, O. N., World, C. & Berk, B. C. Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Antioxid. Redox Signal. 16, 587–596 (2012).
Harijith, A., Ebenezer, D. L. & Natarajan, V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front. Physiol. 5, 352 (2014).
Nishiyama, A. et al. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 274, 21645–21650 (1999).
Tobiume, K. et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2, 222–228 (2001).
Saitoh, M. et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596–2606 (1998).
Zhou, J., Yu, Q. & Chng, W. J. TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms. Int. J. Biochem. Cell Biol. 43, 1668–1673 (2011).
Tsung, A. et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201, 1135–1143 (2005).
Suzuki, S., Toledo-Pereyra, L. H., Rodriguez, F. J. & Cejalvo, D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 55, 1265–1272 (1993).
Kamo, N. et al. ASC/caspase-1/IL-1beta signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology 58, 351–362 (2013).
Acknowledgements
This work was supported by the NIH grants R01AI139552, R21AI146742, R21AI112722, R21AI115133 (B.K.), P01AI120944, R01DK062357, R01DK102110, and R01DK107533 (J.W.K.-W.) and by the Dumont Research Foundation.
Author information
Authors and Affiliations
Contributions
Y.J. and C.L. performed experiments in vitro and in vivo and analyzed the data; D.X. J.Z., S.W., A.Z., M.S., and S.D. performed the in vitro experiments; A.J.C. participated in scientific discussion; Q.X. participated in scientific discussion and data analysis; R.W.B. and J.W.K.-W. were the senior discussants; B.K. contributed to the study concept, research design, and data analysis and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jin, Y., Li, C., Xu, D. et al. Jagged1-mediated myeloid Notch1 signaling activates HSF1/Snail and controls NLRP3 inflammasome activation in liver inflammatory injury. Cell Mol Immunol 17, 1245–1256 (2020). https://doi.org/10.1038/s41423-019-0318-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-019-0318-x
- Springer Nature Limited
Keywords
This article is cited by
-
The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression
Experimental & Molecular Medicine (2024)
-
Loss of macrophage TSC1 exacerbates sterile inflammatory liver injury through inhibiting the AKT/MST1/NRF2 signaling pathway
Cell Death & Disease (2024)
-
Blockade of Notch1 Signaling Alleviated Podocyte Injury in Lupus Nephritis Via Inhibition of NLRP3 Inflammasome Activation
Inflammation (2024)
-
Sesamol defends neuronal damage following cerebral ischemia/reperfusion: a crosstalk of autophagy and Notch1/NLRP3 inflammasome signaling
Inflammopharmacology (2024)
-
Du Huo Ji Sheng Tang inhibits Notch1 signaling and subsequent NLRP3 activation to alleviate cartilage degradation in KOA mice
Chinese Medicine (2023)